Rick Shinto is the Chief Executive Officer and President at InnovaCare Health Solutions. Rick Shinto has more than two decades of experience within the clinical and operational portions of managed care companies.
Rick Shinto earned his first degree from the University of California at Irvine, and additionally earned his second degree from the State University of New York at Stony Brook. His educations has provided him with the knowledge that is required to successfully lead his company, InnovaCare Health Solutions.
The company was founded by Rick Shinto in the year of 1998. Rick practiced as a physician and would go on to obtain some of the best expertise and knowledge in regards to providing health care quality care at low costs, and even more effectively. The company is focused on providing quality health care, and the only way to do that is to have the best physicians available. The company has built its own reputation around helping partners change their creative designs and health care capabilities into models that focus on the efficient aspects and quality aspects of success within the industry.
Some of these aspects of quality care include a selection of values and characteristics that focus on patients coming before business decisions. This is one simple value that many within the industry do not follow, people are more important than revenue. In addition to that, the company also focuses on quality before anything else, because without quality, everything else could fall apart.
They also have a desire to follow specific guidelines to ensure that these characteristics are never forgotten. One of their company beliefs is that a level of transparency has to be sustained in order to ensure the quality satisfaction that patients are looking for when exploring the industry. A solid cooperation of teamwork can make a significant improvement to the quality of the health care, which includes communication and problem solving. Adaptability is also a crucial and imperative trait in order to overcome several of the toughest challenges when working to provide the best managed care.
By following the list of goals that the company and it CEO, Rick Shinto, have provided, InnovaCare will likely continue to build its reputation as one of the best providers of managed health care operations in the country.
Jim Tananbaum is the CEO of Foresite Capital. He was interviewed on Ideamensch earlier this month. Tananbaum explained that the idea of Foresite Capital came about after being involved in the healthcare sector for more than two decades. He realized that companies operating in that space took a longer time and more capital to succeed as compared to other sectors. Tananbaum started the firm to cater to these companies by providing the resources needed for their success. The firm analyzes information about advances in the industry to determine the most viable investment prospects. More details can be found on Ideamensch.
Jim said that most of his day revolves around taking calls, attending meetings, and discussing any updates about Foresite’s portfolio companies. Tananbaum attributes his learning nature to his productivity as an entrepreneur. He was able to grow the firm exponentially when he combined this with persistence and commitment. Jim was asked what he would change if he was able to go back. He answered that he would keep on believing in himself. Doing things as they had always been done led him to make compromises that hindered his growth. Check out Forbes to know more.
Jim Tananbaum is the founder of Foresite Capital. This is an equity firm that invests in healthcare companies. The equity firm also provides information and access to networks. Foresite Capital has recently invested in Intarcia. This is an implant that is injected into diabetes patients twice a year. It helps them to lose weight and control the disease. The product will be launched at the end of this year. Jim believes that it will change the lives of millions of people around the world.
The venture capital firm has invested in Aeri Pharmaceuticals that is developing a glaucoma treatment. The disease is one of the leading causes of blindness. The product will go a long way in reducing these cases. Other companies that the firm has invested in include Editas, Sequenta, and Nanostring. Editas is operating in the synthetic biology space. Sequenta and Nanostring are gene sequencing companies. Jim has led investments in several successful enterprises in the healthcare space including Healtheon, Amira Pharmaceuticals, Jazz Pharmaceuticals, and Amerigroup. Tananbaum has degrees from Harvard University and the Massachusetts Institute of Technology.
Check out the website officialjimtananbaum.com
Read More: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund